Dr Corine Bertolotto is a research Director at INSERM, France. Over the past 20 years, her team has sought to identify the mechanisms involved in cutaneous melanoma development, progression and resistance to treatment with a special focus on the transcription factor MITF. Recently, her team also embarked on projects aimed at studying the molecular mechanisms involved in a more rare form of melanomas occurring in the eye.
